Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-125421
Filing Date
2025-12-23
Accepted
2025-12-23 16:50:12
Documents
2
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0270548-6k_canfite.htm 6-K 11165
2 PRESS RELEASE DATED DECEMBER 23, 2025 ea027054801ex99-1_canfite.htm EX-99.1 12897
  Complete submission text file 0001213900-25-125421.txt   25083
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 251601378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)